vtioВестник трансплантологии и искусственных органовRussian Journal of Transplantology and Artificial Organs1995-1191Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation10.15825/1995-1191-2020-1-26-34vtio-1140Research ArticleКлиническая трансплантологияClinical TransplantologyУровень экспрессии микроРНК в ранние и отдаленные сроки после трансплантации у реципиентов сердцаMicroRNA expression levels in early and long-term period following heart transplantationВеликийД. А.VelikiyD. A.

Великий Дмитрий Алексеевич.

123182, Москва, ул. Щукинская, д. 1.

Velikiy Dmitriy Alekseevich.

1, Shchukinskaya str., Moscow, 123182

dim_vel@mail.ruГичкунО. Е.GichkunO. E.

Москва

Moscow

ШарапченкоС. О.SharapchenkoS. O.

Москва

Moscow

ШевченкоО. П.ShevchenkoO. P.

Москва

Moscow

ШевченкоА. О.ShevchenkoA. O.

Москва

Moscow

ФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава РоссииРоссияShumakov National Medical Research Center of Transplantology and Artificial OrgansRussian FederationФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России; ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России (Сеченовский университет)РоссияShumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov UniversityRussian FederationФГБУ «Национальный медицинский исследовательский центр трансплантологии и искусственных органов имени академика В.И. Шумакова» Минздрава России; ФГАОУ ВО «Первый Московский государственный медицинский университет имени И.М. Сеченова» Минздрава России (Сеченовский университет); ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Минздрава РоссииРоссияShumakov National Medical Research Center of Transplantology and Artificial Organs; Sechenov University; Pirogov Medical UniversityRussian Federation2020210420202212634Copyright © Великий Д.А., Гичкун О.Е., Шарапченко С.О., Шевченко О.П., Шевченко А.О., 20202020Великий Д.А., Гичкун О.Е., Шарапченко С.О., Шевченко О.П., Шевченко А.О.Velikiy D.A., Gichkun O.E., Sharapchenko S.O., Shevchenko O.P., Shevchenko A.O.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.transpl.ru/vtio/article/view/1140трансплантация сердцамикроРНКхроническая сердечная недостаточностьбиомаркерыотторжениеheart transplantationmicroRNAchronic heart failurebiomarkersrejectionReferencesKransdorf EP, Kobashigawa JA. Novel molecular approaches to the detection of heart transplant rejection. Per Med. 2017 Jul; 14 (4): 293–297.Kransdorf EP, Kobashigawa JA. Novel molecular approaches to the detection of heart transplant rejection. Per Med. 2017 Jul; 14 (4): 293–297.Crespo-Leiro MG, Barge-Caballero G, Couto-Mallon D. Noninvasive monitoring of acute and chronic rejection in heart transplantation. Curr Opin Cardiol. 2017 Mar 16. doi: 10.1097/HCO.0000000000000400. [Epub ahead of print].Crespo-Leiro MG, Barge-Caballero G, Couto-Mallon D. Noninvasive monitoring of acute and chronic rejection in heart transplantation. Curr Opin Cardiol. 2017 Mar 16. doi: 10.1097/HCO.0000000000000400. [Epub ahead of print].van Gelder T. Biomarkers in solid organ transplantation. Br J Clin Pharmacol. 2017 Dec; 83 (12): 2602–2604.van Gelder T. Biomarkers in solid organ transplantation. Br J Clin Pharmacol. 2017 Dec; 83 (12): 2602–2604.Великий ДА, Гичкун ОЕ, Шевченко АО. Микро-РНК: роль в развитии сердечно-сосудистых заболеваний, перспективы клинического применения. Клиническая лабораторная диагностика. 2018; 63 (7): 403–409.Velikiy DA, Gichkun OE, Shevchenko AO. MikroRNK: rol’ v razvitii serdechno-sosudistykh zabolevanij, perspektivy’ klinicheskogo primeneniya. Klinicheskaya laboratornaya diagnostika. 2018; 63 (7): 403–409. [In Russ, English abstract].Savic-Radojevic A, Pljesa-Ercegovac M, Matic M et al. Novel biomarkers of heart failure. Advances In Clinical Chemistry. 2017; 79: 93–152.Savic-Radojevic A, Pljesa-Ercegovac M, Matic M et al. Novel biomarkers of heart failure. Advances In Clinical Chemistry. 2017; 79: 93–152.Starling RC, Stehlik J, Baran DA et al. Multicenter analysis of immune biomarkers and heart transplant outcomes: results of the clinical trials in organ transplantation- 05 study. American Journal of Transplantation. 2016; 16: 121–136.Starling RC, Stehlik J, Baran DA et al. Multicenter analysis of immune biomarkers and heart transplant outcomes: results of the clinical trials in organ transplantation- 05 study. American Journal of Transplantation. 2016; 16: 121–136.Di Francesco A, Fedrigo M, Santovito D, Natarelli L, Castellani C, De Pascale F et al. MicroRNA signatures in cardiac biopsies and detection of allograft rejection. J Heart Lung Transplant. 2018 Nov; 37 (11): 1329–1340.Di Francesco A, Fedrigo M, Santovito D, Natarelli L, Castellani C, De Pascale F et al. MicroRNA signatures in cardiac biopsies and detection of allograft rejection. J Heart Lung Transplant. 2018 Nov; 37 (11): 1329–1340.Shah P, Bristow MR, Port JD. MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential. Curr Heart Fail Rep. 2017 Dec; 14 (6): 454–464.Shah P, Bristow MR, Port JD. MicroRNAs in Heart Failure, Cardiac Transplantation, and Myocardial Recovery: Biomarkers with Therapeutic Potential. Curr Heart Fail Rep. 2017 Dec; 14 (6): 454–464.Khush K, Zarafshar S. Molecular Diagnostic Testing in Cardiac Transplantation. Curr Cardiol Rep. 2017 Oct 13; 19 (11): 118.Khush K, Zarafshar S. Molecular Diagnostic Testing in Cardiac Transplantation. Curr Cardiol Rep. 2017 Oct 13; 19 (11): 118.Готье СВ, Шевченко АО, Попцов ВН. Пациент с трансплантированным сердцем: руководство для врачей по ведению пациентов, перенесших трансплантацию сердца. М.: Триада, 2014: 144.Gautier SV, Shevchenko AO, Popcov VN. Pacient s transplantirovannym serdcem: rukovodstvo dlya vrachej po vedeniyu pacientov, perenesshih transplantaciyu serdca. M.: Triada, 2014: 144.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(–Delta Delta C(T)) Method. Methods. 2001 Dec; 25 (4): 402–408.Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(–Delta Delta C(T)) Method. Methods. 2001 Dec; 25 (4): 402–408.Zhang XL, An BF, Zhang GC. MiR-27 alleviates myocardial cell damage induced by hypoxia/reoxygenation via targeting TGFBR1 and inhibiting NF-κB pathway. Kaohsiung J Med Sci. 2019 Oct; 35 (10): 607–614.Zhang XL, An BF, Zhang GC. MiR-27 alleviates myocardial cell damage induced by hypoxia/reoxygenation via targeting TGFBR1 and inhibiting NF-κB pathway. Kaohsiung J Med Sci. 2019 Oct; 35 (10): 607–614.Li X, Zhang S, Wa M, Liu Z, Hu S. MicroRNA-101 Protects Against Cardiac Remodeling Following Myocardial Infarction via Downregulation of Runt-Related Transcription Factor 1. J Am Heart Assoc. 2019 Dec 3; 8 (23): e013112.Li X, Zhang S, Wa M, Liu Z, Hu S. MicroRNA-101 Protects Against Cardiac Remodeling Following Myocardial Infarction via Downregulation of Runt-Related Transcription Factor 1. J Am Heart Assoc. 2019 Dec 3; 8 (23): e013112.Sukma Dewi I, Hollander Z, Lam KK, McManus JW, Tebbutt SJ, Ng RT et al. Association of Serum MiR-142- 3p and MiR-101-3p Levels with Acute Cellular Rejection after Heart Transplantation. PLoS One. 2017; 12 (1): e0170842.Sukma Dewi I, Hollander Z, Lam KK, McManus JW, Tebbutt SJ, Ng RT et al. Association of Serum MiR-142- 3p and MiR-101-3p Levels with Acute Cellular Rejection after Heart Transplantation. PLoS One. 2017; 12 (1): e0170842.

The authors declare that there are no conflicts of interest present.